Biotech Values

[DewDiligence]

GTCB
Greg Liposky (SVP, Operations) sold 20K shares at $1.01 last Friday, according a Form-4 filed today. This is half of the 2005 bonus of roughly 40K shares Liposky received on March 10 (#msg-10161756).

GTC’s recent actions vis-à-vis bonuses and option grants are not helping the company reestablish credibility in the investment community (see my email in #msg-10161990). Further, although GTC has no direct control over what insiders do with their (unrestricted) shares, it will harm the company’s credibility even further if insiders make a habit of unloading shares at the current price.